Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katharina Grohs"'
Autor:
Brigitta Stöckelmeier, Manuela Födinger, Veronika Leitner-Ferenc, Sonja Jansen-Skoupy, Katharina Grohs, Johanna Atamaniuk
Publikováno v:
Laboratory medicine. 48(2)
Background Reference intervals provided by diagnostic test manufacturers should be transferred to clinical laboratories after validation. Although protocols exist, laboratories rarely perform and report on results of validation studies. Methods We va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b93dd30bec45c1ab6cfd5aecc27e0b1
https://pubmed.ncbi.nlm.nih.gov/28398583
https://pubmed.ncbi.nlm.nih.gov/28398583
Analytical and clinical performance of a new molecular assay for Epstein-Barr virus DNA quantitation
Autor:
Michael Bozic, Petra M. Konrad, Margit Hübner, Katharina Grohs, Harald H. Kessler, Brigitte I. Santner
Publikováno v:
Journal of virological methods. 212
Quantitation of EBV DNA has been shown to be a useful tool to identify and monitor patients with immunosuppression and high risk for EBV-associated disease. In this study, the analytical and clinical performance of the new Realquality RS-EBV Kit (AB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ab6ff19a2703f0e22bc0088bb99291
https://pubmed.ncbi.nlm.nih.gov/25445796
https://pubmed.ncbi.nlm.nih.gov/25445796
Autor:
Andrea Podczeck-Schweighofer, Georg Delle-Karth, Jolanta M. Siller-Matula, Marcel Francesconi, Günter Christ, Carina Gruber, Bernd Jilma, Cornelia Dechant, Katharina Grohs
Publikováno v:
Clinical science (London, England : 1979). 128(2)
This was a prospective study comparing two groups: personalized and non-personalized treatment with P2Y12 receptor blockers during a 12-month follow-up. We aimed to investigate whether personalized antiplatelet treatment in patients with high on-trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e317061c0d3f7c1c0c914055bfb973
https://pubmed.ncbi.nlm.nih.gov/25124236
https://pubmed.ncbi.nlm.nih.gov/25124236
Autor:
Andrea Podczeck-Schweighofer, Katharina Grohs, Jolanta M. Siller-Matula, Marcel Francesconi, Thomas Hafner, Eva Wilhelm, Günter Christ
Publikováno v:
Thrombosis research. 132(1)
Current guidelines still recommend the bolus and infusion administration of glycoprotein IIbIIIa inhibitors in patients with high-risk acute coronary syndrome undergoing percutaneous coronary intervention. We sought to evaluate the extent of platelet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89a042102f2c567640b8314267c53c39
https://pubmed.ncbi.nlm.nih.gov/23791395
https://pubmed.ncbi.nlm.nih.gov/23791395
Autor:
Günter Christ, Cornelia Dechant, Jolanta M. Siller-Matula, Andrea Podczeck-Schweighofer, Katharina Grohs, Marcel Francesconi
Publikováno v:
BMJ Open
ObjectiveTo evaluate the clinical utility of individualising dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in an all-comers population, including ST-elevation myocardial infarction (STEMI) patients.SettingTertiary ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c5302423522a2ba3151b5564e303c29
https://doi.org/10.1136/bmjopen-2014-005781
https://doi.org/10.1136/bmjopen-2014-005781